THE EFFICACY OF RECOMBINANT ACTIVATED FACTOR VII (COAGIL VII) FOR TREATMENT HAEMORRHAGE AND HAEMOSTASIS DISORDES DURING THORACIC AORTA OPERATIONS
Goal: to evaluate the efficacy and safety of domestic (home-produced) recombinant factor VIIa (Coagil VII) for massive bleeding and haemostasis disordes treatment in thoracic aorta surgery. Methods. 82 patients undergoing surgery on thoracic aorta with cardiopulmonary bypass and circulatory arrest s...
Saved in:
Main Authors: | N. A. TREKOVA, D. A. GUSKOV, A. V. GONCHAROVA, B. A. AKSELROD |
---|---|
Format: | Article |
Language: | Russian |
Published: |
New Terra Publishing House
2019-07-01
|
Series: | Вестник анестезиологии и реаниматологии |
Subjects: | |
Online Access: | https://www.vair-journal.com/jour/article/view/333 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Application of Recombinant VII Activated Coagulation Factor for Children with Resistant Coagulopathy Caused Sepsis
by: N. Bgane, et al.
Published: (2010-06-01) -
The features of the mode of delivery in patients with congenital deficiency of coagulation factor VII: case reports
by: A. Yu. Bulanov, et al.
Published: (2020-12-01) -
Prevention of hemorrhagic complications during operations on the thoracic aorta
by: D. C. Panfilov, et al.
Published: (2018-12-01) -
Architectures and urban landscapes in Pompeii the project of Sapienza University in the Regio VII
by: Maria Teresa D'Alessio, et al.
Published: (2023-10-01) -
The king in love: Edward VII's mistresses /
by: Aronson, Theo
Published: (1988)